← back to search

Ruth Brauer

University of London ·
Area of research
Psychiatry and Mental health · Public Health, Environmental and Occupational Health
Research interest
Research interests include Dementia and Cognitive Impairment Research, Maternal Mental Health During Pregnancy and Postpartum, Pharmaceutical Practices and Patient Outcomes, and Schizophrenia research and treatment.
h-index
25
citations
1,970
works
72
NIH funding
primary concept
email

Recent publications

Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study
Age and Ageing 2025cited by 10position: middledoi
Hormone replacement therapy prescribing in menopausal women in the UK: a descriptive study
BJGP Open 2022cited by 50position: lastdoi
Stakeholders’ views on the use of psychotropic medication in older people: a systematic review
Age and Ageing 2022cited by 24position: middledoi
Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age
JAMA Internal Medicine 2021cited by 88position: middledoi
Antipsychotic drug use in pregnancy: A multinational study from ten countries
Schizophrenia Research 2020cited by 53position: middledoi
Application of Healthcare ‘Big Data’ in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN)
CNS Drugs 2020cited by 27position: middledoi
Trazodone use and risk of dementia: A population-based cohort study
PLoS Medicine 2019cited by 36position: firstdoi
Patient decision aids for antidepressant use in pregnancy: a pilot randomised controlled trial in the UK
BJGP Open 2019cited by 33position: middledoi
Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK
Journal of Autism and Developmental Disorders 2019cited by 32position: lastdoi
Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self‐controlled study designs
British Journal of Clinical Pharmacology 2016cited by 25position: middledoi
Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case–control studies using two primary care databases in Europe
Pharmacoepidemiology and Drug Safety 2016cited by 17position: firstdoi
Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
PLoS Medicine 2015cited by 125position: firstdoi
Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States
PLoS Medicine 2015cited by 109position: middledoi
Prevalence of antibiotic use: a comparison across various European health care data sources
Pharmacoepidemiology and Drug Safety 2015cited by 55position: firstdoi
The risk of acute liver injury associated with the use of antibiotics—evaluating robustness of results in the pharmacoepidemiological research on outcomes of therapeutics by a European consortium (PROTECT) project.
Pharmacoepidemiology and Drug Safety 2015cited by 13position: middledoi
The risk of acute liver injury among users of antibiotic medications: a comparison of case‐only studies.
Pharmacoepidemiology and Drug Safety 2015cited by 9position: firstdoi
Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study
European Heart Journal 2014cited by 41position: firstdoi
Ascertainment of acute liver injury in two European primary care databases
European Journal of Clinical Pharmacology 2014cited by 32position: middledoi
Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink
BMJ 2013cited by 71position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Liam Smeeth · Qatar University8 papers (2013–2016)Ian Douglas · London School of Hygiene & Tropical Medicine7 papers (2014–2016)Ian Chi Kei Wong · Advanced Materials Enterprises (China)5 papers (2016–2025)Maurille Feudjo Tepie · Amgen (United States)4 papers (2014–2016)Kenneth K. C. Man · University of London4 papers (2019–2021)Olaf H. Klungel · Utrecht University4 papers (2014–2016) · 4 papers (2014–2016)Robert F. Reynolds · Tulane University4 papers (2014–2016)Francisco J. de Abajo · Universidad de Alcalá3 papers (2014–2016)Luis A. Garcı́a Rodrı́guez · University of Kentucky3 papers (2014–2016)Andrew Bate · London School of Hygiene & Tropical Medicine3 papers (2014–2016)Mark de Groot · London School of Hygiene & Tropical Medicine3 papers (2014–2016) · 3 papers (2014–2016)Raymond G. Schlienger · Novartis (Switzerland)3 papers (2014–2016)Krishnan Bhaskaran · Centre de recherche en Epidémiologie et Santé des Populations3 papers (2013–2016) · 2 papers (2014–2015) · 2 papers (2014–2015)Li Wei · University of London2 papers (2021–2022)Matthew Adesuyan · University of London2 papers (2022–2025)Sarah Cook · London School of Hygiene & Tropical Medicine2 papers (2022–2022)